Skip to content

Clinical trials

Observational Neoplasm Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Observational Clear all

437 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20038
20047
20056
20068
200714
200815
200917
201019
201112
201215
201314
201422
201523
201616
201716
201816
201926
202026
202130
202234
202322
202422
202514
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed182
Unknown status94
Recruiting73
Terminated28
Active, not recruiting23
Not yet recruiting23
Withdrawn10
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center9
National Taiwan University Hospital8
University Health Network, Toronto8
National Cancer Institute (NCI)7
Chang Gung Memorial Hospital6
Norwegian University of Science and Technology6
Assistance Publique - Hôpitaux de Paris5
Bristol-Myers Squibb5
Mayo Clinic5
Peking University Cancer Hospital & Institute5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis437
Breast Neoplasms79
Neoplasms63
Colorectal Neoplasms43
Carcinoma, Non-Small-Cell Lung34
Recurrence34
Lung Neoplasms31
Prostatic Neoplasms30
Liver Neoplasms24
Carcinoma, Hepatocellular21

Trials

Showing 1 to 25 of 437. Each trial links to its page on Pharma Observatory.

337 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.